📰 globenewswire.com/news-relea… Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements 🔹Both previously disclosed Nasdaq compliance matters are now closed $TVGN @Nasdaq #Compliance

📰 globenewswire.com/news-relea… Tevogen is a healthcare enterprise focused on improving the affordability and accessibility of life-saving medicines. The Company brings together three complementary efforts: @TevogenBio, its biotechnology initiative; @TevogenAI, its artificial intelligence and technology initiative; and @TevogenHS its healthcare services, its emerging healthcare services initiative. Together, these efforts are designed to create a more integrated healthcare model in which science, technology, and operational efficiency work together to reduce the cost of medication and expand patient access. “We are not simply building a biotechnology company. We are building a healthcare enterprise,” said @DrRyanSaadi, MD, MPH, Founder and Chief Executive Officer of Tevogen. #TVGN

Tevogen Bio Announces 2026 Annual Meeting of Stockholders 📰 globenewswire.com/news-relea… The Annual Meeting will be held virtually. Stockholders of record as of July 23, 2026 will be entitled to receive notice of and vote at the Annual Meeting or any adjournment thereof. $TVGN